Brain metastases from lung cancer with neuropsychiatric symptoms as the first symptoms
نویسندگان
چکیده
منابع مشابه
neurologic manifestations as the presenting symptoms in lung cancer
this case series reports 100 patients with lung cancer and their presenting neurologic symptoms and sings. 78% of patients were maleand 22% were female. mean age was 62±1.04 years with a peak age between 65 and 75 years. most patients presented with pulmonary problems (58%) and neurologic deficits as the presenting manifestations were found to be 30% along with pulmonary symptoms and 12% laking...
متن کاملInsulinoma Presenting with Neuropsychiatric Symptoms.
An insulinoma is a rare pancreatic endocrine tumor which is typically a hypervascular, solitary small tumour. 90 % of tumors are benign and less than 2 cm in size. Some insulinomas are associated with MEN-1 syndrome. Some cases of insulinoma may present with neuropsychiatric symptoms and may be wrongly diagnosed as psychosis. We report a case of insulinoma in a 55 years old female who presented...
متن کاملBrain metastases secondary to breast cancer: symptoms, prognosis and evolution.
AIMS AND BACKGROUND Brain metastases confer a worse prognosis to breast cancer because they determine a severe increase in mortality. The aim of this study was to identify the early symptoms in patients with brain metastases after breast cancer treatment and to evaluate the median survival rate in women with single and operable brain lesions. PATIENTS AND METHODS We examined 43 patients with ...
متن کاملGefitinib as a first line of therapy in non-small cell lung cancer with brain metastases.
Two Japanese women were diagnosed as having well-differentiated adenocarcinoma of the lung with brain metastases. Since it was considered they could not tolerate conventional chemotherapy, we administered gefitinib without any previous systemic therapy. In both patients gefitinib acted dramatically on all the lesions including the brain metastases, resulting in a marked decrease of the elevated...
متن کاملPemetrexed/cisplatin as first-line chemotherapy for advanced lung cancer with brain metastases
BACKGROUND Brain metastases (BMs) are a common and serious complication of non-small cell lung cancer (NSCLC). Whole-brain radiotherapy (WBRT), surgery, and molecular targeted therapy are usually used to treat NSCLC with BM. Chemotherapeutic options for BM are limited by tumor resistance, ineffective agents, and the blood-brain barrier. Pemetrexed/cisplatin is the preferred chemotherapy in nons...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Translational Lung Cancer Research
سال: 2019
ISSN: 2218-6751,2226-4477
DOI: 10.21037/tlcr.2019.10.02